The Aporia
Guardian staff. (2026, August 28). FDA approves updated Covid-19 vaccines for dominant XFG variant. The Guardian. https://www.theguardian.com/us-news/2026/aug/27/fda-approves-updated-covid-19-vaccines
Guardian staff. “FDA approves updated Covid-19 vaccines for dominant XFG variant.” The Guardian, 28 Aug. 2026, https://www.theguardian.com/us-news/2026/aug/27/fda-approves-updated-covid-19-vaccines.
Guardian staff. “FDA approves updated Covid-19 vaccines for dominant XFG variant.” The Guardian, August 28, 2026. https://www.theguardian.com/us-news/2026/aug/27/fda-approves-updated-covid-19-vaccines.
Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.
The US Food and Drug Administration (FDA) has approved updated Covid-19 vaccines from Moderna, Novavax-Sanofi, and Pfizer-BioNTech to target the dominant XFG variant. The vaccines are now allowed to be shipped to pharmacies and doctors' offices across the country. They are approved for individuals 65 and older, as well as younger individuals with underlying conditions that make them more susceptible to severe Covid-19 outcomes. This decision comes after an advisory panel recommended targeting the XFG variant, which has become dominant. The updated vaccines were previously expected to be available by the 2026-27 immunization season, and it's unclear if this approval will meet that timeline.